HIV/AIDS Treatment and Care : Clinical protocols for the European ...

HIV/AIDS TREATMENT AND CARE FOR INJECTING DRUG USERS
22. WHO, UNODC, UNAIDS. Reduction of HIV transmission in prisons. Geneva, World Health Organization,
2004 (Evidence for Action on HIV/AIDS and Injecting Drug Use Policy Brief, HIV/2004.05;
http://www.who.int/hiv/pub/advocacy/en/transmissionprisonen.pdf, accessed 17 April 2006).
23. WHO, UNODC, UNAIDS. Reduction of HIV transmission through outreach. Geneva, World Health Organization,
2004 (Evidence for Action on HIV/AIDS and Injecting Drug Use Policy Brief, HIV/2004.02;
http://www.who.int/hiv/pub/advocacy/en/throughoutreachen.pdf, accessed 17 April 2006).
24. Aceijas C et al. Global overview of injecting drug use and HIV infection among injecting drug users.
AIDS, 2004, 18:2295–2303.
25. Report of the global HIV/AIDS epidemic. Geneva, UNAIDS, 2002.
26. Joint UNAIDS statement on HIV prevention and care strategies for drug users. Geneva, UNAIDS, 2005
(http://www.data.unaids.org/UNA-docs/CCO_IDUPolicy_en.pdf, accessed 17 April 2006).
27. Rhodes T et al. HIV infection associated with drug injecting in the newly independent states, eastern
Europe: the social and economic context of epidemics. Addiction,1999, 94:1323–1336.
28. Rhodes T, Simic M. Transition and risk environment. BMJ, 2005, 331:220–223.
29. Donoghoe MC. Injecting drug use, harm reduction and HIV/AIDS. In Matic S, Lazarus JV, Donoghoe
MC, eds. HIV/AIDS in Europe: moving from death sentence to chronic disease management, Copenhagen,
WHO Regional Office for Europe, 2006.
30. Kelly JA, Amirkhanian YA. The newest epidemic: a review of HIV/AIDS in central and eastern Europe.
International Journal of STD & AIDS, 2003, 14:361–371.
31. De la Fuente L et al. Lessons from the history of the HIV/AIDS epidemic among Spanish drug injectors.
Clinical Infectious Diseases, 2003, 37 Suppl. 5:S410–S415.
32. Grassly NC et al. Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission
in the Russian Federation, China and India. International Journal of Drug Policy, 2003,
14:25–43.
33. Shakarishvili A et al. Sex work, drug use, HIV infection, and spread of sexually transmitted infections
in Moscow, Russian Federation. The Lancet, 2005, 366:57–60.
34. Donoghoe MC, Lazarus JV, Matic S. HIV/AIDS in the transitional countries of eastern Europe and
central Asia. Clinical Medicine, 2005, 5 (5):487–490.
35. WHO, UNODC, UNAIDS. Substitution maintenance therapy in the management of opioid dependence
and HIV/AIDS prevention [position paper]. Geneva, World Health Organization, 2004 (http://whqlibdoc.who.int/unaids/2004/9241591153.pdf,
accessed 17 April 2006).
36. Rimland D et al. Prospective study of etiologic agent of community-acquired pneumonia in patients
with HIV infection. AIDS, 2002, 16:85–95.
37. Regier D et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the
Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 1990,
264(19):2511–2518.
38. Bouhnik AD et al. Non-adherence among HIV-infected injecting drug users: the impact of social instability.
Journal of Acquired Immune Deficiency Syndromes, 2002, 31(Suppl. 3):S149–153.
39. Bouhnik AD et al. Depression and clinical progression in HIV-infected drug users treated with highly
active antiretroviral therapy. Antiviral Therapy, 2005, 10(1):53–61.
40. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2004: the state
of the drugs problem in the European Union and Norway. Luxembourg, Office for Official Publications
of the European Communities, 2004.
41. EMCDDA. Reviewing current practice in drug–substitution treatment in the European
Union, Luxembourg, Office for Official Publications of the European Communities, 2000
(Insights No. 3).
42. Auriacombe M et al. French field experience with buprenorphine. American Journal of Addiction, 2004,
13(Suppl. 1):S17–S28.
43. Inungu J, Beach EM, Skeel R. Challenges facing health professionals caring for HIV-infected drug users.
AIDS Patient Care and STDs, 2003, 17(7):333–343.
44. Des Jarlais DC, Semaan S. Interventions to reduce the sexual risk behaviour of injecting drug users.
International Journal of Drug Policy, 2005, 16(Suppl.):S58–S66.
45. Farrell M et al. Effectiveness of drug dependence treatment in HIV prevention. International Journal of
Drug Policy, 2005, 16(Suppl.):S67–S75.
46. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programmes. International Journal of
Drug Policy 2005, 16(Suppl.):S31–S44.
219